Analytical Data
-
Gene name
UNQ2446
- Application
-
Alternative Names
MRCC2446; Neuritin-like Protein; Nrn1l; NRN1L_HUMAN; UNQ2446/PRO5725
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q496H8
-
Expression Region
36-139 aa
-
AA Sequence
AAGPN RCDTIYQGFA ECLIRLGDSM GRGGELETIC RSWNDFHACA SQVLSGCPEE AAAVWESLQQ EARQAPRPNN LHTLCGAPVH VRERGTGSET NQETLRATA
-
Molecular Weight
17.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UNQ2446 is a recombinant protein that has garnered attention in the field of molecular biology and biomedicine due to its potential therapeutic applications. Identified through high-throughput sequencing and bioinformatics analyses, UNQ2446 is believed to be involved in critical biological processes, including cell signaling and immune response modulation. Research into this protein is driven by the increasing demand for novel protein targets in drug development, particularly for diseases where traditional therapies have limited efficacy. Early studies suggest that UNQ2446 may play a role in specific pathways associated with cancer and autoimmune disorders, making it a candidate for further exploration. Additionally, its recombinant nature allows for detailed structural and functional analyses, paving the way for understanding its mechanisms of action. This research aligns with broader initiatives aimed at utilizing recombinant DNA technology to generate proteins with therapeutic potential, contributing to advancements in personalized medicine and targeted therapies. By elucidating the properties and interactions of UNQ2446, scientists aim to unlock new strategies for tackling complex diseases, highlighting the importance of continued investigation into this protein's functional attributes.
